LIfT Biosciences is a socially-minded Biotech start-up commercialising Leukocyte Infusion Therapy (LiFT), building on 18 years of ground breaking research. LIfT BioSciences has a patent pending technology platform for developing the World’s first and only Cell Bank of Cancer Killing Neutrophils for all solid tumours. Our first mission is to have Developed a Cure for Pancreatic Cancer by 2021. We have successfully cultured The World’s 1st Cancer Killing Neutrophils and completed SEED funding.
Connect with LIfT BioSciences